Characterizing esophageal mixed neuroendocrine–non-neuroendocrine neoplasms: insights from a retrospective multicenter study of clinical outcomes and prognostic indicators
Therapeutic Advances in Medical Oncology · 2024-01 · 16
DOI: 10.1177/17588359241303066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 07.12.2024. Verfasst von Qian Hong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China, Ministry of Science and Technology of the People’s Republic of China.
Abstract (Originalsprache)
Background
The esophageal mixed neuroendocrine–non-neuroendocrine neoplasm (MiNEN) is an extremely rare but poor prognosis tumor.
Objectives
This retrospective study aimed to analyze the clinical characteristics of MiNEN and to investigate postoperative survival and prognostic factors.
Design
This retrospective study analyzed 69 patients diagnosed with esophageal MiNEN at two major esophageal cancer centers in China from January 2000 to December 2021.
Methods
We assessed demographic data, tumor characteristics, treatment modalities, and survival outcomes. Statistical analyses included Kaplan–Meier survival curves and Cox regression models to evaluate prognostic factors.
Results
The most common histological types were combinations of small-cell carcinoma and squamous carcinoma (91.3%). The correct diagnostic rate of preoperative pathologic biopsy was only 4.3%. The median overall survival (OS) was 24.0 months, and disease-free survival (DFS) was 16.6 months. The 1-, 3-, and 5-year survival rates were 84.1%, 34.8%, and 25.3%, respectively. A peak period of recurrence or metastasis occurs in the first year after surgery, and regional lymph node recurrence is the main route of postoperative recurrence or metastasis. Tumor size, T-stage, N-stage, and tumor, lymph node, metastasis (TNM) stage were significant prognostic factors. Subgroup analyses showed that in patients with limited-stage MiNEN in stages I–III, the postoperative adjuvant treatment modality failed to improve OS and DFS compared with surgery alone. Postoperative adjuvant therapy also failed to prolong OS and DFS in patients with lymph node-positive MiNEN. No significant survival benefits were observed with different surgical techniques or adjuvant chemotherapy regimens.
Conclusion
Esophageal MiNEN has aggressive behavior and a poor prognosis. In China, the pathologic type of esophageal MiNEN may be dominated by a combination of small-cell carcinoma and squamous carcinoma. Early-stage disease significantly correlated with improved survival outcomes. Current treatment protocols, similar to those for other esophageal cancers, show limited efficacy in improving patient survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, No. 218, Ji Xi Road, Hefei 230000, Anhui, China.
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoya…
ORCID-Profile: Qian Hong, Qiuju Zhang, Rui Han, Juwei Mu
Förderung
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Hong, Q., Wu, K., Chen, C., Dang, Y., Zhang, Q., Zhang, X., Wang, L., Han, R., Zhao, C., Yi, H., Li, F., Zhang, R., Mu, J., & Li, J. (2024). Characterizing esophageal mixed neuroendocrine–non-neuroendocrine neoplasms: insights from a retrospective multicenter study of clinical outcomes and prognostic indicators. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359241303066
Vancouver
Hong Q, Wu K, Chen C, Dang Y, Zhang Q, Zhang X, et al. Characterizing esophageal mixed neuroendocrine–non-neuroendocrine neoplasms: insights from a retrospective multicenter study of clinical outcomes and prognostic indicators. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241303066
BibTeX
@article{Hong2024,
author = {Hong, Qian and Wu, Kaiming and Chen, Chen and Dang, Yan and Zhang, Qiuju and Zhang, Xue and Wang, Liting and Han, Rui and Zhao, Chenguang and Yi, Hang and Li, Fang and Zhang, Renquan and Mu, Juwei and Li, Jiagen},
title = {Characterizing esophageal mixed neuroendocrine–non-neuroendocrine neoplasms: insights from a retrospective multicenter study of clinical outcomes and prognostic indicators},
journal = {Therapeutic Advances in Medical Oncology},
year = {2024},
volume = {16},
doi = {10.1177/17588359241303066}
}
EUVIMED